Banner image
HealthQuad

India’s leading healthcare focused venture & growth capital fund.

Included in the AvH investment portfolio since 2017
(Fund I) and 2020 (Fund II).

36.27 %

Beneficial interest AvH

Fund I

10.98 %

Beneficial interest AvH

Fund II

Press releases - Growth capital 

View All
Growth Capital

Biotalys Obtains Subscription Commitments for EUR 12.05 Million through a Private Placement of New Shares with Current Investors

Growth Capital

Confo Therapeutics Announces Phase 2 Clinical Trial Initiation by Lilly for Peripheral Pain Candidate, CFTX-1554

Growth Capital

Biotalys Reports Full-Year 2025 Financial Results and Business Highlights